Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-5,554,656 |
Disinfectant concentrates and disinfectants on amine and alcohol base
and their use The invention relates to a disinfectant concentrate which contains amine and alcohol wherein the alcohol component includes at least one glycol ether of limited... |
| US-5,554,655 |
Method of treating HIV infection Cysteamine, cystamine, and phosphocysteamine are effective agents for the treatment of HIV infections. |
| US-5,554,654 |
Method for enhancing the therapeutic effect of an anti-acne agent Composition and method for enhancing therapeutic effects of topically applied agents are disclosed. The cosmetic or therapeutic composition may include one or... |
| US-5,554,653 |
Inhibitors of HIV protease useful for the treatment of AIDS The present invention provides novel HIV protease inhibitors, pharmaceutical formulations containing those compounds and methods of treating and/or preventing... |
| US-5,554,652 |
Method of treating wrinkles using alpha hydroxyacids, alpha ketoacids
and a sunscreen agent Composition and method for enhancing therapeutic effects of topically applied agents are disclosed. The cosmetic or therapeutic composition may include one or... |
| US-5,554,651 |
Method of treating wrinkles using citramalic acid Composition and method for enhancing therapeutic effects of topically applied agents are disclosed. The cosmetic or therapeutic composition may include one or... |
| US-5,554,650 |
Antiphlogistic, analgesic, antipyretic injection preparation An antiphlogistic, analgesic, antipyretic parenteral preparation is disclosed comprising diclofenac, its salt, or both, a surfactant, cosurfactant, water, having... |
| US-5,554,649 |
Controlling agent for fabric pest insects A controlling agent for fabric pest insects characterized by containing, as an active ingredient, a carboxylic acid ester represented by the formula (I): ... |
| US-5,554,648 |
Cobalt complexes as anticancer agents New cobalt complexes of nitrogen mustard alkylating agents which have been found to have hypoxia-selective antitumor properties and are thereby useful antitumor... |
| US-5,554,647 |
Method and compositions for treatment and/or prevention of skin damage
and aging One or more precursors of acetylcholine such as dimethylaminoethanol in a dermatologically acceptable carrier is a topical treatment for aging skin and muscles.... |
| US-5,554,646 |
Method for reducing body fat in animals A method of reducing body fat comprises administering to the animal a safe and effective amount of a conjugated linoleic acid. Methods of preserving or... |
| US-5,554,645 |
Antineoplastic cocoa extracts and methods for making and using the same Disclosed and claimed are cocoa extracts such as polyphenols or procyanidins, methods for preparing such extracts, as well as uses for them, especially as... |
| US-5,554,644 |
Tachykinin (NK.sub.2) antagonists The compounds of the instant invention are ligands for the NK.sub.2 receptor. The compounds are modified at the C-terminus to provide various amide isostere... |
| US-5,554,643 |
Pro-drugs for CCK antagonists Novel pro-drugs to new and unnatural depeptoids of .alpha.-substituted Trp-Phe derivatives useful as agents in the treatment of obesity, hypersecretion of... |
| US-5,554,642 |
Arylalkyl(thio) amides A compound which is selected from those of formula (I): ##STR1## in which A, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined in the... |
| US-5,554,641 |
Nonpeptides as tachykinin antagonists The small nonpeptides of the instant invention are tachykinin antagonists. The compounds are highly selective and functional NK.sub.3 antagonists expected to be... |
| US-5,554,640 |
Use of propanolamine derivatives as selective 5-HT.sub.1 antagonists This invention provides a method of selectively antagonizing-the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Aryloxypropanolamines... |
| US-5,554,639 |
Medicaments 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate salt (2:1) and pharmaceutically acceptable solvates thereof are disclosed. The... |
| US-5,554,638 |
Methods for improving therapeutic effectiveness of agents for the
treatment of solid tumors and other disorders The present invention is directed to the use of an inhibitor of NO activity, such as a nitric oxide scavenger or an NO synthase inhibitor, as an antitumor... |
| US-5,554,637 |
Use of leflunomide for inhibiting interleukin 1 alpha N-(4-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide is an effective compound for preventing and treating disorders in which interleukin 1 alpha is... |
| US-5,554,636 |
N-acylated 4-hydroxphenylamine derivatives with analgesic properties and
pharmaceutical compositions containing... The present invention relates to a series of new N-acylated 4-hydroxyphenylamine derivatives, linked via an alkylene bridge to the nitrogen atom of a... |
| US-5,554,635 |
Liquid isothiazolinone concentrates having improved low
temperature-stability and improved anti-bacterial... A liquid concentrate comprises between about 4 and about 10 wt % of an isothiazolinone compound or mixture of isothiazolinone compounds, between about 25 and... |
| US-5,554,634 |
N-(hydroxyethyl)butanediamide derivatives Disclosed herein are compounds of the formula: wherein A' is HO--CR.sup.5 (R.sup.6)CH.sub.2 wherein R.sup.5 and R.sup.6 together with the carbon atom to which they... |
| US-5,554,633 |
Substituted amines as tachykinin receptor antagonists Compounds of formula (I), and salts and prodrugs thereof, wherein Q is optionally substituted phenyl or benzhydryl; X and Y are each H or together form a... |
| US-5,554,632 |
Benzimidazole compounds The present patent application discloses compounds having the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein R.sup.3, R.sup.4, ... |
| US-5,554,631 |
5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinyl benzimidazole derivatives The present invention relates to a novel compound 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivative having the following formula (I): ... |
| US-5,554,630 |
Benzimidazole compounds The present patent application discloses compounds having the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein R.sup.3, R.sup.4, ... |
| US-5,554,629 |
4-substituted 1,2,4-triazole derivatives A discrete class of 4-substituted 1,2,4-triazole derivatives are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of... |
| US-5,554,628 |
Method for minimizing the uterothrophic effect of tamoxifen and
tamoxifen analogs The present invention provides a method of minimizing the uterotrophic effect of non-steroidal antiestrogen compounds of formula II ##STR1## and wherein the... |
| US-5,554,627 |
Tachykinin antagonists Compounds of formula (I), wherein Q.sup.1 represents an aryl group; the dotted line represents an optional covalent bond; one of X and Y represents H and the... |
| US-5,554,626 |
Substituted heterocyclic compounds as dopamine-reuptake inhibitors The present invention discloses compounds of the formula ##STR1## any mixture thereof, or a pharmaceutically acceptable salt thereof; wherein R, R.sup.3,... |
| US-5,554,625 |
Substituted biphenylmethylimidazopyridines Biphenylmethylimidazopyridines of the structure (I) are angiotensin (II) antagonists and therefore useful in the treatment of hypertension and related... |
| US-5,554,624 |
Imidazopyridine derivatives as angiotensin II antagonists The present invention relates to new imidazopyridine derivatives of formula I ##STR1## wherein: one of A, B, C and D is N and the other are CR, wherein each... |
| US-5,554,623 |
Method for the long term reduction of body fat stores, insulin
resistance, hypersinsulinemia and hyperglycemia... A process for the long term modification and regulation of lipid and glucose metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or... |
| US-5,554,622 |
Asymmetrically substituted bisnaphthalimides Asymmetrically substituted bisnaphthalimides of the formula I ##STR1## in which A, B, D, R.sup.1, R.sup.2, m and have the meanings stated in the ... |
| US-5,554,621 |
Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of nitrogen heterocyclic derivatives of 4-phenyl-1,4-dihydropyridines of... |
| US-5,554,620 |
Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and
compositions and methods of use thereof Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts, pharmaceutical compositions containing them, and methods for the treatment of neurodegenerative... |
| US-5,554,619 |
Microbicides Microbicidal composition for use in plants, having a synergistic action and comprising at least two active ingredient components, in which component I is a... |
| US-5,554,618 |
Intravenously administrable aqueous solution An intravenously administrable, aqueous solution of a water-soluble, physiologically tolerable salt of sulfametrole and of trimethoprim, in which malic acid,... |
| US-5,554,617 |
Method for treating cancer with 6-aryl pyrimidine compounds A method for altering the immunoregulatory system of humans and animals by administering a compound of the formula: ##STR1## wherein X.sub.3 is equal to X,... |
| US-5,554,616 |
Fungicidal mixtures A fungicidal mixture containing a) the oxime ether carboxamide of the formula I ##STR1## and either b.1 the oxime ether carboxylic acid ester of the formula II ... |
| US-5,554,615 |
Condensed pyrimidine derivative A novel pyrimidine derivative having an excellent antitumor activity, which is represented by the following general formula (I) or a pharmacologically acceptable... |
| US-5,554,614 |
2-[(4-heteroaryl-1-piperazinyl)alkyl]-1,3-dioxanes and related compounds
and their therapeutic utility Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. The compounds are especially useful for treating psychoses... |
| US-5,554,613 |
Heterocyclic derivatives Quinuclidine derivatives of formula I, and their pharmaceutically acceptable salts, ##STR1## in which R.sup.1 is hydrogen or hydroxy; R.sup.2 is hydrogen;... |
| US-5,554,612 |
4-amino 6-substitutes mycophenolic acid and derivatives The disclosed derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or... |
| US-5,554,611 |
Use of coumarin derivatives The present invention consequently relates to the use of coumarins of the general formula I ##STR1## in which R.sup.1 and R.sup.6 are defined as indicated... |
| US-5,554,610 |
Inhalational treatment of pulmonary hypertension and related conditions A method for the treatment and/or prophylaxis of disorders associated with pulmonary hypertension and/or disorders associated with right heart failure, in... |
| US-5,554,608 |
Inhibition of hair growth Mammalian hair growth is reduced by applying to the skin a composition including an inhibitor of protein kinase C. |
| US-5,554,607 |
Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of
atherosclerosis A method for increasing the HDL cholesterol concentration in the blood of a mammal in need of increased HDL cholesterol blood concentration, which comprises... |
| US-5,554,606 |
Antibiotic compounds The present invention provides a compound of the formula (I) ##STR1## wherein: R.sup.1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R.sup.2 is hydrogen or... |
Copyright 2008−2012 Patents.com
